PCs treatment reduced MFG-E8, phospho-ERK1/2, phospho-Akt, and phospho-GSK-3β levels in db/db mouse kidneys, indicating MFG-E8’s influence on the progression of diabetic nephropathy. This evidence concerns the gene AKT1 and diabetic kidney disease.